BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Do C, Barnes JL, Tan C, Wagner B. Type of MRI contrast, tissue gadolinium, and fibrosis. Am J Physiol Renal Physiol 2014;307:F844-55. [PMID: 25100280 DOI: 10.1152/ajprenal.00379.2014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Idée J, Fretellier N, Robic C, Corot C. The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update. Critical Reviews in Toxicology 2014;44:895-913. [DOI: 10.3109/10408444.2014.955568] [Cited by in Crossref: 66] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
2 Sousa NR, Rocha S, Santos-Silva A, Coimbra S, Valente MJ. Cellular and molecular pathways underlying the nephrotoxicity of gadolinium. Toxicol Sci 2021:kfab148. [PMID: 34878122 DOI: 10.1093/toxsci/kfab148] [Reference Citation Analysis]
3 Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review. Am J Kidney Dis 2021;77:517-28. [PMID: 32861792 DOI: 10.1053/j.ajkd.2020.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rah YC, Han EJ, Park S, Rhee J, Koun S, Park H, Choi J. In vivo assay of the potential gadolinium-induced toxicity for sensory hair cells using a zebrafish animal model: Gadolinium-induced Hair Cell Toxicity. J Appl Toxicol 2018;38:1398-404. [DOI: 10.1002/jat.3656] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Li X, Sun L, Wei X, Luo Q, Cai H, Xiao X, Zhu H, Luo K. Stimuli-responsive biodegradable and gadolinium-based poly[N-(2-hydroxypropyl) methacrylamide] copolymers: their potential as targeting and safe magnetic resonance imaging probes. J Mater Chem B 2017;5:2763-74. [DOI: 10.1039/c6tb03253b] [Cited by in Crossref: 11] [Article Influence: 2.2] [Reference Citation Analysis]
6 Wallnöfer EA, Thurner GC, Kremser C, Talasz H, Stollenwerk MM, Helbok A, Klammsteiner N, Albrecht-Schgoer K, Dietrich H, Jaschke W, Debbage P. Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles. Histochem Cell Biol 2021;155:19-73. [PMID: 33040183 DOI: 10.1007/s00418-020-01919-0] [Reference Citation Analysis]
7 Yokoyama M, Shiraishi K. Stability evaluation of Gd chelates for macromolecular MRI contrast agents. MAGMA 2020;33:527-36. [PMID: 31823277 DOI: 10.1007/s10334-019-00805-8] [Reference Citation Analysis]
8 Bruno F, DeAguero J, Do C, Lee DY, Tan C, Escobar GP, Wagner B. Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis. Am J Physiol Renal Physiol 2021;320:F617-27. [PMID: 33615889 DOI: 10.1152/ajprenal.00456.2020] [Reference Citation Analysis]
9 McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH, Jacobs PM, Lenkinski RE, Maravilla KR, Prince MR, Rowley HA, Tweedle MF, Kressel HY. Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. Radiology 2018;289:517-34. [PMID: 30204075 DOI: 10.1148/radiol.2018181151] [Cited by in Crossref: 121] [Cited by in F6Publishing: 93] [Article Influence: 30.3] [Reference Citation Analysis]
10 Luiza da Silva Queiroz M, Bezerra Diniz PR, Nepomuceno Montenegro EJ, de Souza Costa Neto JJ, Santana de Albuquerque Filho E, Valença MM, Sobral de Oliveira Souza AI, da Silva Tenório A, Wanderley D, de Oliveira DA. MRI in migraineurs: are there abnormalities in the area where the myofascial trigger points are palpable and in volume measurements? J Bodyw Mov Ther 2020;24:260-6. [PMID: 32825998 DOI: 10.1016/j.jbmt.2020.02.025] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ozawa Y, Hayashi S, Hamasaki Y, Hatamochi A. Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts. Arch Dermatol Res 2016;308:695-701. [DOI: 10.1007/s00403-016-1689-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Wu Y, Briley K, Tao X. Nanoparticle-based imaging of inflammatory bowel disease: Nano-based imaging of IBD. WIREs Nanomed Nanobiotechnol 2016;8:300-15. [DOI: 10.1002/wnan.1357] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
13 Wagner B, Drel V, Gorin Y. Pathophysiology of gadolinium-associated systemic fibrosis. Am J Physiol Renal Physiol 2016;311:F1-F11. [PMID: 27147669 DOI: 10.1152/ajprenal.00166.2016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
14 Knoepp F, Bettmer J, Fronius M. Gadolinium released by the linear gadolinium-based contrast-agent Gd-DTPA decreases the activity of human epithelial Na+ channels (ENaCs). Biochim Biophys Acta Biomembr 2017;1859:1040-8. [PMID: 28257815 DOI: 10.1016/j.bbamem.2017.02.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 Sherrah AG, Grieve SM, Jeremy RW, Bannon PG, Vallely MP, Puranik R. MRI in Chronic Aortic Dissection: A Systematic Review and Future Directions. Front Cardiovasc Med 2015;2:5. [PMID: 26664877 DOI: 10.3389/fcvm.2015.00005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
16 Do C, Ford B, Lee DY, Tan C, Escobar P, Wagner B. Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptors. Toxicol Appl Pharmacol 2019;375:32-45. [PMID: 31082427 DOI: 10.1016/j.taap.2019.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Leyba K, Wagner B. Gadolinium-based contrast agents: why nephrologists need to be concerned. Curr Opin Nephrol Hypertens 2019;28:154-62. [PMID: 30531473 DOI: 10.1097/MNH.0000000000000475] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
18 Kasper JY, Hermanns MI, Cavelius C, Kraegeloh A, Jung T, Danzebrink R, Unger RE, Kirkpatrick CJ. The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro. Int J Nanomedicine 2016;11:6353-64. [PMID: 27994454 DOI: 10.2147/IJN.S92608] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
19 Yee J. Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House. Advances in Chronic Kidney Disease 2017;24:133-5. [DOI: 10.1053/j.ackd.2017.03.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
20 Do C, Drel V, Tan C, Lee D, Wagner B. Nephrogenic Systemic Fibrosis Is Mediated by Myeloid C-C Chemokine Receptor 2. J Invest Dermatol 2019;139:2134-2143.e2. [PMID: 30978353 DOI: 10.1016/j.jid.2019.03.1145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
21 Rogosnitzky M, Branch S. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms. Biometals 2016;29:365-76. [PMID: 27053146 DOI: 10.1007/s10534-016-9931-7] [Cited by in Crossref: 336] [Cited by in F6Publishing: 265] [Article Influence: 56.0] [Reference Citation Analysis]
22 Marasini R, Thanh Nguyen TD, Aryal S. Integration of gadolinium in nanostructure for contrast enhanced-magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1580. [PMID: 31486295 DOI: 10.1002/wnan.1580] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
23 Arda K, Akay S, Erisken C. Effect of gadolinium concentration on temperature change under magnetic field. PLoS One 2019;14:e0214910. [PMID: 30947239 DOI: 10.1371/journal.pone.0214910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Riser BL, Barnes JL, Varani J. Balanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer. J Cell Commun Signal 2015;9:327-39. [PMID: 26698861 DOI: 10.1007/s12079-015-0309-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
25 Do C, DeAguero J, Brearley A, Trejo X, Howard T, Escobar GP, Wagner B. Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution. Kidney360 2020;1:561-8. [PMID: 34423308 DOI: 10.34067/kid.0000272019] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Drel VR, Tan C, Barnes JL, Gorin Y, Lee DY, Wagner B. Centrality of bone marrow in the severity of gadolinium-based contrast-induced systemic fibrosis. FASEB J 2016;30:3026-38. [PMID: 27221979 DOI: 10.1096/fj.201500188R] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
27 Dong YC, Bouché M, Uman S, Burdick JA, Cormode DP. Detecting and Monitoring Hydrogels with Medical Imaging. ACS Biomater Sci Eng 2021;7:4027-47. [PMID: 33979137 DOI: 10.1021/acsbiomaterials.0c01547] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Russo M, Ponsiglione AM, Forte E, Netti PA, Torino E. Hydrodenticity to enhance relaxivity of gadolinium-DTPA within crosslinked hyaluronic acid nanoparticles. Nanomedicine (Lond) 2017;12:2199-210. [PMID: 28816102 DOI: 10.2217/nnm-2017-0098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
29 Prybylski JP, Coste Sanchez C, Jay M. Impact of chelation timing on gadolinium deposition in rats after contrast administration. Magn Reson Imaging 2019;55:140-4. [PMID: 30321663 DOI: 10.1016/j.mri.2018.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]